N-type calcium channel blockers - Tools for modulation of cerebral functional units?

Brain Research

Volumn 855, Issue 2, 2000, Pages 225-234

  Haubrich, C ^a   Frielingsdorf, V ^a   Herzig, S ^a   Schroder H ^a   Schwarting, R ^b   Sturm, V ^a   Voges, J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Conotoxin; D2 dopamine receptors; Motor activity; N type calcium channel; Rotation; Striatum

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE 2 RECEPTOR; OMEGA CONOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; LOCOMOTION; MALE; MOTOR ACTIVITY; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; ROTATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; APOMORPHINE; BRAIN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CORPUS STRIATUM; DOPAMINE; FUNCTIONAL LATERALITY; HOMOVANILLIC ACID; INFUSIONS, PARENTERAL; MALE; MOTOR ACTIVITY; OMEGA-CONOTOXIN GVIA; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 0034645933     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02356-2     Document Type: Article

References (40)

1. Adeyemo O.M., Shapira S., Tombaccini D., Pollard H.B., Feuerstein G., Siren A.L. A goldfish model for evaluation of the neurotoxicity of ω-conotoxin GVIA and screening of monoclonal antibodies. Toxicol. Appl. Pharmacol. 108:1991;489-496.
2. Argiolas A., Melis M.R., Stancampiano R., Gessa G.L. ω-Conotoxin prevents apomorphine and oxytocin-induced penile erection and yawning in male rats. Pharmacol. Biochem. Behav. 37:1990;253-257.
3. Bergquist F., Jonason J., Pileblad E., Nissbrandt H. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra, A microdialysis study in rat. J. Neurochem. 70:1998;1532-1540.
4. Bowersox S.S., Gadbois T., Singh T., Pettus M., Wang Y.X., Luther R.R. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J. Pharmacol. Exp. Ther. 279:1996;1243-1249.
5. Brown P., Marsden C.D. What do the basal the basal ganglia do? The Lancet. 351:1998;1801-1804.
6. L Cadet J.-, Last R., Kostic V., Przedborski S., Jackson-Lewis V. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen. Brain Res. Bull. 26:1991;707-713.
7. Cadet J.L., Zhu S.M. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat. Brain Res. 595:1992;316-326.
8. Carey R.J. Relationship of changes in spontaneous motor behavior to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. Exp. Neurobiol. 92:1986;591-600.
9. Chaplan S.R., Pogrel J.W., Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther. 269:1994;1117-1123.
10. Fishman R.h.B., Feigenbaum J.J., Yanai J., Klawans H.L. The relative importance of dopamine and norepinephrine in mediating locomotor activity. Prog. Neurobiol. 20:1983;55-88.
11. Fornaguera J., Schwarting W.R.K., Boix F., Huston J.B. Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical parkinson's model. Synapse. 13:1993;179-185.
12. Fornaguera J., Carey R.J., Dai H., Huston J.P., Schwarting R.K.W. Differentiation of motor inactivation from asymmetry effects in an animal model of hemi-parkinsonism. NeuroReport. 6:1994;173-176.
13. Gundersen H.J.G., Bagger T., Bentsen S.M., Evans S.M., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J.R., Pakkenberg P., Sørensen F.B., Vesterby A., West M.J. The new stereological tools: dissector, fractionator, nucleator, and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:1988;857-881.
14. Harsing L.G., Sershen H., Vizi S.E., Lajtha A. N-type calcium channels are involved in the dopamine releasing effect of nicotine. Neurochem. Res. 17:1992;729-734.
15. 3H ]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats Brain Res. 211:1981;285-292.
16. 3H ]sulpiride binding sites in rat brain Neurosci. Lett. 51:1984;47-53.
17. Kato T., Otsu Y., Furune Y., Yamamoto T. Different effects of L-, N-, and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rats. Neurochem. Int. 21:1992;99-107.
18. Kroin J.S., Penn R.D. Intracerebral chemotherapy: chronic microinfusion of cisplatin. Neurosurgery. 10:1982;349-354.
19. Mandel R.J., Hartgraves S.L., Severson J.A., Woodward J.J., Wilcox R.E., Randall P.K. A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion-induced agonist sensitivity in the rat. Behav. Brain Res. 59:1993;53-64.
20. McKenzie J.S., Shafton A.D., Stewart C.A. Intrastriatal dopaminergic agents, muscarinic stimulation, and GABA antagonism compared for rotation responses in rats. Behav. Brain Res. 45:1991;163-170.
21. Meyer E.M., Cottrell G.A., Van Hartesfeldt C. Intracerebral haloperidol potentiates the dorsal immobility response in the rat. Pharmacol. Biochem. Behav. 44:1993;157-160.
22. 11C ]DOPA Brain Res. 578:1992;122-128.
23. Morgan S., Nomikos G., Huston J.P. Changes in the nigrostriatal projection associated with recovery from lesion-induced behavioral asymmetry. Behav. Brain Res. 46:1991;157-165.
24. Naoi M., Maruyama W., Dostert P., Hashizume Y., Nakahara D., Takahashi T., Ota M. Dopamine-derived endogenous 1(R), 2(N)-dimethyl-6,7.dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsosinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Res. 709:1996;285-295.
25. 2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis. Br. J. Pharmacol. 123:1998;805-814.
26. Oorshot D.E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigra nuclei of the rat basal ganglia: a stereological study using the calavieri and optical disector methods. J. Comp. Neurol. 366:1996;580-599.
27. L.J. Pellegrino, A.S. Pellegrino, A.J. Cushman, (Eds.), A Stereotaxic Atlas for the Rat Brain, 2nd edn., Plenum, New York, 1979.
28. Pellevoisin C., Guilloteau D., Baulieu J., Loc'h C., Dognon A.M., Mauclaire L., Saccarini J.C., Besnard J.C., Chalon S. Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors. Synapse. 24:1996;79-86.
29. Pruneau D., Angus J.A. ω-Conotoxin GVIA, the N-type calcium channel inhibitor, is sympatholytic but not vagolytic: Consequences for hemodynamics and autonomic reflexes in conscious rats. J. Cardiovasc. Pharmacol. 16:1990;675-680.
30. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D.M. Dose dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-647.
31. Pycock C.J., Marsden C.D. The rotating rodent: a two component? Eur. J. Pharamacol. 47:1978;167-175.
32. Schwarting R.K.W., Huston J.P. Short-term effects of ether, equitesin and droperidol/fentanyl on catecholamine and indolamine metabolism in the brain of the rat. Neuropharmacology. 26:1987;457-461.
33. Schwarting R.K.W., Huston J.P. The unilateral 6-hydroxydopamine lesion in behavioral brain research. Analysis of functional deficits recovery and treatments. Prog. Neurobiol. 50:1996;275-331.
34. Takemura M., Kiyama H., Fukui H., Tohyama M., Wada H. Distribution of the o,ega-conotoxin receptor in rat brain. An autoradiographic mapping. Neuroscience. 32:1989;405-416.
35. Tarazi F.I., Cambell A., Yeghiayan S.K., Baldessarini R.J. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: Comparison of D1-, D2-, and D4-like receptors. Neuroscience. 83:1998;169-176.
36. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9518-9522.
37. West M.J., Ostergaard K., Andreassen O.A., Finsen B. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J. Comp. Neurol. 370:1996;11-22.
38. West M.J., Slomianka L., Gundersen H.J.G. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231:1991;482-497.
39. Whorlow S.L., Loiacono R.E., Angus J.A., Wright C.E. Distribution of N-type Ca2+ channel binding sites in rabbit brain following central administration of ω-conotoxin GVIA. Eur. J. Pharmacol. 315:1996;11-18.
40. Yung K.K.L., Bolam J.P., Smith A.D., Hersch S.M., Ciliax B.J. Immunohistochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.